Key terms
About RGC
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest RGC news
Apr 23
1:08pm ET
Regencell Bioscience Holdings Ltd trading resumes
Apr 23
12:58pm ET
Regencell Bioscience Holdings Ltd trading halted, volatility trading pause
Mar 01
3:31pm ET
Regencell Bioscience Holdings Ltd trading resumes
Mar 01
3:26pm ET
Regencell Bioscience Holdings Ltd trading halted, volatility trading pause
No recent press releases are available for RGC
RGC Financials
Key terms
Ad Feedback
RGC Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
RGC Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range